Challenges in IPF diagnosis, current management and future perspectives: Patient case 2

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 32, Issue , 2015, Pages 38-39

  Margaritopoulos, George ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PIRFENIDONE; PREDNISOLONE; CORTICOSTEROID; PYRIDONE DERIVATIVE;

AGED; ANTIBIOTIC THERAPY; ARTICLE; BRONCHITIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; CRACKLE; DRUG WITHDRAWAL; FIBROSING ALVEOLITIS; FOLLOW UP; HUMAN; INTERSTITIAL LUNG DISEASE; LOW DRUG DOSE; MALE; PHOTOSENSITIVITY DISORDER; PRIORITY JOURNAL; SKIN MANIFESTATION; CORONARY ARTERY DISEASE; DOSE RESPONSE; DRUG ERUPTIONS; HEMOPTYSIS; HYPERTENSION; IDIOPATHIC PULMONARY FIBROSIS; PROCEDURES; RADIOGRAPHY; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TACHYCARDIA, SUPRAVENTRICULAR; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; AGED; CORONARY ARTERY DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ERUPTIONS; FOLLOW-UP STUDIES; HEMOPTYSIS; HUMANS; HYPERTENSION; IDIOPATHIC PULMONARY FIBROSIS; MALE; PYRIDONES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TACHYCARDIA, SUPRAVENTRICULAR; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84938700278     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Fell CD, Liu LX, et al. Clinical predictors of a diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2010; 181 (8): 832-7.
2. Antoniou KM, Symvoulakis EK, Margaritopoulos GA, et al. Early diagnosis of IPF: time for a primary-care case-finding initiative? Lancet Respir Med 2014; 2(1): e1.
3. Noble PW, Albera C, Bradford WZ, et al. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. Lancet 2011; 377: 1760-9.
4. King TE Jr, Bradford WZ, Castro-Bernardini S, et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med 2014 May 29; 370 (22): 2083-92.
5. Costabel U, Bendstrup E, Cottin V, et al. Pirfenidone in idiopathic pulmonary fibrosis: expert panel discussion on the management of drug-related adverse events. Adv Ther 2014; 31: 375-9.